COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations through December 31, 2020.

Mayo Clinic Talks COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

Mayo Clinic Talks

Mayo Clinic Talks Podcast #140
COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

 

Registration required for CME credit

Mayo Clinic Employees - no charge. Login with your Mayo Clinic email to access this offer.

 
Listen on Apple Podcast  Listen on Google Play Music  Listen on Spotify

You can also listen through your favorite podcast platform:
Apple Podcasts | Google Play Music | Stitcher | Spotify

COVID-19 information evolves daily.  The views and perspectives shared in these resources are presented based on information available at the time of recording.

Recorded Friday, March 27, 2020
For the most up to date information visit:

CDC - Information for Healthcare Professionals about Coronavirus (COVID-19)
World Health Organization's Country & Technical Guidance - Coronavirus disease (COVID-19)
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19


Christina G. Rivera, Pharm.D., R.Ph. &
Ryan W. Stevens, Pharm.D. Twitter @Stevens_AK
Hosted by: Raymund R. Razonable, M.D. Twitter @RazonableMD

Chloroquine emerged as an early COVID-19 treatment option in China and there has been increasing interest in the use of hydroxychloroquine and azithromycin. What data is available for the safety and efficacy of the drugs in the fight against SARS-CoV-2? Dr. Christina Rivera and Dr. Ryan Stevens provide a breakdown of recent research.

 

Target Audience

This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants

Learning Objectives

Upon completion of this Mayo Clinic Talks Podcast episode, learners should be able to:

  • Recall the suspected mechanism of action for hydroxychloroquine in treatment of COVID-19
  • Recall the proposed pharmacokinetics and pharmacodynamics for hydroxychloroquine in the treatment of COVID-19
  • Distinguish between the acute versus chronic effects of hydroxychloroquine use
  • Recall the impact of widespread usage of azithromycin and hydroxychloroquine for treatment of COVID-19 on the treatment of other infectious diseases

Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit
  • 0.50 Attendance
Course opens: 
03/27/2020
Course expires: 
12/29/2022
Cost:
$10.00

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Available Credit

  • 0.50 AMA PRA Category 1 Credit
  • 0.50 Attendance

Price

Cost:
$10.00
Please login or register to take this course.

Thank you for joining us!  

Everything you need to complete this course is listed in the Course Progress column on this page's left-hand side.  This handy checklist has all of the course components needing completion.  Do them in any order, but completion of all is required for credit.
 

For cancellation details, contact cme@mayo.edu